The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water soluble, non peptidic oligomer.
                            本发明涉及寡聚体-
PTK
抑制剂偶联物和相关化合物(除其他事项外)。本发明中的化合物在通过多种给药途径之一给予时,表现出优于缺乏
水溶性非肽寡聚体的
PTK
抑制剂化合物的优点。